- Details
- Bernard Bochner and Arnulf Stenzl join Wei Shen Tan in a conversation on selecting the appropriate urinary diversion method for bladder cancer patients. Dr. Bochner emphasized that this decision is highly individualized and depends on factors such as renal and hepatic function, urethral involvement, and previous colon surgeries. The long-term outcomes of continent diversions and ileal conduits wer...
|
- Details
- In this conversation hosted by Ashish Kamat, Professors Param Mariappan and Maria Carmen Mir debate the pros and cons of organ-sparing cystectomy in bladder cancer patients. Professor Param Mariappan opposed the motion of organ preservation, highlighting the challenges and complexities associated with preserving reproductive organs for continence and sexual function. He discussed the limitations o...
|
- Details
- In this conversation hosted by Ashish Kamat, Professors Morgan Roupret and Laura Mertens debate the best treatment for a healthy patient with very high-risk non-muscle-invasive bladder cancer (NMIBC). They discuss the classification and risk stratification of bladder cancer according to the European Association of Urology (EAU) guidelines. They also delve into the treatment options for a specific...
|
- Details
- The 2023 AUA annual meeting included the Bladder Cancer Forum, featuring a debate discussing whether skilled urologists need photodynamic diagnosis (PDD) to perform an optimal TURBT. Drs. Michael Cookson and Trinity Bivalacqua, who were participants in this debate, join Dr. Neal Shore to highlight the takeaways from the session. Cookson argued against the use of blue light due to the limitations a...
|
- Details
- Ashish Kamat, Joan Palou, and Fred Witjes discuss optimal management of high-grade T1 bladder cancer. This rapid-fire debate is formatted as each speaker has a position to defend and they will each offer their view for why that treatment is optimal. Biographies: J. Alfred Witjes, MD, Ph.D., Full professor at the Radboud Institute for Molecular Life Sciences, Faculty of Medical Sciences, Chair of O...
|
- Details
- Barton Grossman joins Ashish Kamat in highlighting the 25th anniversary of the International Bladder Cancer Network (IBCN). The 2022 meeting is being held again in Barcelona, Spain, from September 29 – October 1. Dr. Grossman shares reflections on the cooperative efforts of the Bladder Cancer Marker Network of the National Cancer Institute (NCI), which focuses on developing and assessing biomarker...
|
- Details
- Ashish Kamat is joined by Marek Babjuk, Morgan Roupret, and Wassim Kassouf for a rapid-fire debate on the management of small local recurrence low-grade bladder tumors with negative cytology. The patient in this debate is an 81-year-old male with multiple medical comorbidities. Dr. Morgan Roupret argues for formal TURBT with intravesical chemotherapy while Dr. Wassim Kassouf argues for active surv...
|
- Details
- Debate presenter, Peter Black joins Ashish Kamat along with discussants Jens Bedke, and Hugh Mostafid about urinary diversion in patients undergoing radical cystectomy. The 2021 European Association of Urology (EAU) annual meeting had a Controversies in Bladder Cancer Rapid-fire Debates session and here in this UroToday conversation, the group expands on their presentations with Ashish Kamat. Dr....
|
- Details
- In this discussion, debate presenter, Sima Porten, joins Ashish Kamat along with discussants Ananya Choudhury, Paolo Gontero, and Kamal Pohar. The 2021 European Association of Urology (EAU) annual meeting had a Controversies in Bladder Cancer Rapid-fire debates session and here in this UroToday conversation, the group expands on their presentations with Ashish Kamat. The group takes part in a conv...
|
- Details
- With the oncological safety of TURBT unknown, staging inaccuracies are commonplace, and correct treatment of muscle-invasive bladder cancer is potentially delayed. The BladderPath study is looking at using a multiparametric magnetic resonance imaging (mpMRI) scan to diagnose bladder cancer that has grown into the muscle. Drs. Jim Catto and Gary Steinberg join Dr. Ashish Kamat in a discussion about...
|
